Profile data is unavailable for this security.
About the company
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.
- Revenue in THB (TTM)15.68bn
- Net income in THB1.99bn
- Incorporated1982
- Employees5.51k
- LocationMega Lifesciences PCLFloor 9 and 10, Ample Tower Building120 Mu 11, Bangna-Trat RoadBangnaBANGKOK 10280ThailandTHA
- Phone+66 27694222
- Fax+66 27694244
- Websitehttps://www.megawecare.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polynovo Ltd | 2.04bn | 38.43m | 34.80bn | 237.00 | 908.70 | 20.89 | 366.28 | 17.04 | 0.0023 | 0.0023 | 0.1207 | 0.10 | 0.9084 | 1.01 | 7.28 | 388,440.70 | 1.71 | -9.03 | 1.98 | -10.92 | 94.30 | 93.52 | 1.88 | -10.49 | 4.52 | -0.582 | 0.1817 | -- | 59.53 | 61.65 | -312.95 | -- | 47.35 | -- |
| Procter & Gamble Health Ltd | 5.49bn | 1.01bn | 34.81bn | 1.41k | 34.57 | 9.72 | 31.04 | 6.33 | 136.55 | 136.55 | 745.23 | 485.49 | 1.15 | 2.51 | 10.40 | 8,791,756.00 | 21.02 | -- | 27.67 | -- | 69.97 | -- | 18.32 | -- | 2.79 | 383.03 | 0.0132 | -- | 10.34 | -- | 19.19 | -- | -- | -- |
| Youcare Pharmaceutical Group Co Ltd | 20.44bn | 775.92m | 35.77bn | 3.19k | 46.10 | 1.95 | -- | 1.75 | 0.3373 | 0.3373 | 8.88 | 7.99 | 0.6805 | 2.18 | 3.96 | 1,253,963.00 | 2.65 | 8.25 | 3.94 | 15.07 | 59.07 | 63.81 | 3.89 | 8.51 | 1.30 | -- | 0.1794 | 53.50 | -8.53 | 10.96 | -38.57 | 15.70 | 39.08 | -- |
| Mega Lifesciences PCL | 15.68bn | 1.99bn | 35.96bn | 5.51k | 18.05 | 3.87 | 15.78 | 2.29 | 2.29 | 2.29 | 17.99 | 10.67 | 1.09 | 2.12 | 4.88 | 2,844,399.00 | 13.86 | 14.06 | 21.21 | 22.34 | 45.25 | 42.78 | 12.71 | 12.57 | 1.42 | 4.29 | 0.0264 | 47.14 | -0.0322 | 8.68 | -11.10 | 10.56 | -17.15 | 17.64 |
| Strides Pharma Science Ltd | 17.56bn | -677.34m | 36.07bn | 2.85k | -- | -- | 137.25 | 2.05 | -16.88 | -10.96 | 436.72 | -- | -- | -- | -- | 13,871,790.00 | -- | -0.9448 | -- | -1.59 | 58.90 | 49.75 | -4.37 | -2.19 | -- | 0.9061 | -- | -- | 20.13 | 5.33 | 51.93 | -- | -25.10 | -5.59 |
| Harbin Pharmaceutical Group Co., Ltd. | 79.01bn | 2.02bn | 36.47bn | 9.85k | 17.56 | 1.51 | -- | 0.4616 | 0.1612 | 0.1612 | 6.26 | 1.88 | 1.12 | 6.18 | 3.63 | 1,568,718.00 | 3.44 | 0.7414 | 9.50 | 1.89 | 25.45 | 23.87 | 3.07 | 0.7294 | 1.03 | 29.34 | 0.4664 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
| Chengdu Easton Biopharmaceuticals Co Ltd | 5.90bn | 1.23bn | 36.55bn | 1.40k | 29.61 | 2.70 | -- | 6.19 | 2.01 | 2.01 | 9.65 | 22.07 | 0.3566 | 1.54 | 7.73 | 824,469.80 | 7.43 | 8.72 | 9.15 | 10.64 | 77.92 | 85.10 | 20.84 | 19.16 | 2.59 | -- | 0.0861 | 26.80 | -4.56 | 7.76 | -8.09 | 10.91 | 17.99 | -- |
| China Shineway Pharmaceutical Group Ltd | 23.08bn | 4.95bn | 36.56bn | 3.53k | 6.74 | 1.02 | 6.24 | 1.58 | 1.39 | 1.39 | 6.46 | 9.19 | 0.5073 | 1.44 | 6.31 | -- | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 45.79 | 14.32 | 11.94 | 34.14 | 13.89 | -- | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 7.21bn | 2.55bn | 36.73bn | 798.00 | 14.38 | 2.01 | 11.54 | 5.09 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Lepu Biopharma Co Ltd | 1.15bn | -112.91m | 36.87bn | 429.00 | -- | 8.05 | 97.35 | 32.02 | -0.0144 | -0.0144 | 0.1468 | 0.5842 | 0.0917 | 1.06 | 1.62 | 567,748.90 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1392 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Everest Medicines Ltd | 643.51m | -4.32bn | 36.94bn | 432.00 | -- | 1.43 | -- | 57.40 | -2.92 | -2.92 | 0.4348 | 16.82 | 0.0203 | 2.25 | 4.57 | 315,068.20 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| KAKEN PHARMACEUTICAL CO., LTD. | 17.14bn | 705.22m | 37.02bn | 1.13k | 43.37 | 0.9158 | 27.23 | 2.16 | 78.14 | 78.14 | 1,915.49 | 3,700.49 | 0.429 | 1.86 | 2.89 | 63,801,770.00 | 1.76 | 8.17 | 2.00 | 9.56 | 53.89 | 55.55 | 4.11 | 16.09 | 4.68 | -- | 0.0267 | 44.04 | -4.01 | -5.81 | -43.03 | -22.17 | 3.16 | 0.00 |
| Cisen Pharmaceutical Co Ltd | 22.89bn | 2.70bn | 37.22bn | 3.40k | 13.82 | 1.24 | -- | 1.63 | 1.16 | 1.16 | 9.86 | 13.02 | 0.6082 | 2.81 | 5.65 | 1,315,959.00 | 7.21 | 6.94 | 9.02 | 8.56 | 57.33 | 56.27 | 11.85 | 10.77 | 3.12 | -- | 0.0373 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
Data as of Apr 25 2024. Currency figures normalised to Mega Lifesciences PCL's reporting currency: Thai Baht THB
7.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 23.92m | 2.74% |
| Aberdeen Asset Management (Thailand) Co., Ltd.as of 28 Dec 2023 | 12.08m | 1.39% |
| Somerset Capital Management LLPas of 30 Sep 2023 | 7.67m | 0.88% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 4.47m | 0.51% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 3.60m | 0.41% |
| abrdn Australia Ltd.as of 28 Dec 2023 | 2.88m | 0.33% |
| Epoch Investment Partners, Inc.as of 31 Dec 2023 | 2.06m | 0.24% |
| SCB Asset Management Co., Ltd.as of 28 Dec 2023 | 1.84m | 0.21% |
| AllianceBernstein Ltd.as of 31 Dec 2023 | 1.72m | 0.20% |
| FIL Investment Management (Singapore) Ltd.as of 29 Feb 2024 | 1.55m | 0.18% |
More ▼
Data from 28 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
